Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19

Ploutarchos Tzoulis, Julian Waung, Emmanouil Bagkeris, Ziad Hussein, Aiyappa Biddanda, J. W. Cousins, Alice Dewsnip, Kanoyin Falayi, Will McCaughran, Chloe Mullins, Ammara Naeem, Muna Nwokolo, Helen Quah, Syed Bitat, Eithar Deyab, Swarupini Ponnampalam, Pierre-Marc Bouloux, Hugh Montgomery, Stephanie E Baldeweg

The Journal of Clinical Endocrinology & Metabolism · 2021

Read source ↗ All evidence

Summary

CONTEXT: Dysnatremia is an independent predictor of mortality in patients with bacterial pneumonia. There is paucity of data about the incidence and prognostic impact of abnormal sodium concentration in patients with coronavirus disease 2019 (COVID-19). OBJECTIVE: This work aimed to examine the association of serum sodium during hospitalization with key clinical outcomes, including mortality, need for advanced respiratory support and acute kidney injury (AKI), and to explore the role of serum sodium as a marker of inflammatory response in COVID-19. METHODS: This retrospective longitudinal cohort study, including all adult patients who presented with COVID-19 to 2 hospitals in London over an 8-week period, evaluated the association of dysnatremia (serum sodium < 135 or > 145 mmol/L, hyponat

Source type
Peer-reviewed study
DOI
10.1210/clinem/dgab107
Catalogue ID
BFmokjo2bz-zo2ad1
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.